Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 346 AL 360

Shi-Jiang Li, PhD, Recipient of 2017 Alzheimer Award

J Alzheimers Dis. 2017;59(2):387-388. doi: 10.3233/JAD-179004.

Environmental Factors Promoting Neural Plasticity: Insights from Animal and Human Studies

Mandolesi L, Gelfo F, Serra L, Montuori S, Polverino A, Curcio G, Sorrentino G.

Neural Plast. 2017;2017:7219461. doi: 10.1155/2017/7219461. Epub 2017 Jun 14.

Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus

Zhao Y, Jaber V, Lukiw WJ.

Front Cell Infect Microbiol. 2017 Jul 11;7:318. doi: 10.3389/fcimb.2017.00318. eCollection 2017.

The TMA-93: A New Memory Test for Alzheimer's Disease in Illiterate and Less Educated People

Maillet D, Narme P, Amieva H, Matharan F, Bailon O, Le Clésiau H, Belin C.

Am J Alzheimers Dis Other Demen. 2017 Dec;32(8):461-467. doi: 10.1177/1533317517722630. Epub 2017 Jul 27.

Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity

Aleksis R, Oleskovs F, Jaudzems K, Pahnke J, Biverstål H.

Biochimie. 2017 Sep;140:176-192. doi: 10.1016/j.biochi.2017.07.011. Epub 2017 Jul 25.

An acetylation-phosphorylation switch that regulates tau aggregation propensity and function

Carlomagno Y, Chung DC, Yue M, Castanedes-Casey M, Madden BJ, Dunmore J, Tong J, DeTure M, Dickson DW, Petrucelli L, Cook C.

J Biol Chem. 2017 Sep 15;292(37):15277-15286. doi: 10.1074/jbc.M117.794602. Epub 2017 Jul 31.

Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts

Itzhaki RF.

FASEB J. 2017 Aug;31(8):3216-3226. doi: 10.1096/fj.201700360.

Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease

Lee JK, Kim NJ.

Molecules. 2017 Aug 2;22(8):1287. doi: 10.3390/molecules22081287.

APP mouse models for Alzheimer's disease preclinical studies

Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, Hardy J, Vassar R, Winblad B, Saido TC.

EMBO J. 2017 Sep 1;36(17):2473-2487. doi: 10.15252/embj.201797397. Epub 2017 Aug 1.

Resolution of inflammation, n-3 fatty acid supplementation and Alzheimer disease: A narrative review

Fraga VG, Carvalho MDG, Caramelli P, de Sousa LP, Gomes KB.

J Neuroimmunol. 2017 Sep 15;310:111-119. doi: 10.1016/j.jneuroim.2017.07.005. Epub 2017 Jul 12.

MicroRNA Dysregulation in Alzheimer's Disease

Putteeraj M, Fairuz YM, Teoh SL.

CNS Neurol Disord Drug Targets. 2017;16(9):1000-1009. doi: 10.2174/1871527316666170807142311.

Alzheimer's disease pathology and shunt surgery outcome in normal pressure hydrocephalus

Yasar S, Jusue-Torres I, Lu J, Robison J, Patel MA, Crain B, Carson KA, Hoffberger J, Batra S, Sankey E, Moghekar A, Rigamonti D.

PLoS One. 2017 Aug 7;12(8):e0182288. doi: 10.1371/journal.pone.0182288. eCollection 2017.

Lessons from Anti-Amyloid-β Immunotherapies in Alzheimer Disease: Aiming at a Moving Target

Wang Y, Yan T, Lu H, Yin W, Lin B, Fan W, Zhang X, Fernandez-Funez P.

Neurodegener Dis. 2017;17(6):242-250. doi: 10.1159/000478741. Epub 2017 Aug 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias